期刊文献+

骨保护素的临床应用 被引量:4

下载PDF
导出
摘要 骨保护素(osteoprotegerin,OPG)是肿瘤坏死因子(tumor necrosis factor,TNF)受体家族的新成员,最初于1997年被两个独立的实验室同时发现,也被称为破骨细胞抑制因子(ostelclastogenesis inhibitory factor,OCIF),具有抑制破骨细胞的功能。近年来,随着医学研究人员与分子生物学研究人员及药学研究人员的广泛深入的合作,人们已经发现骨保护素在骨代谢中的作用机制;除此之外,
出处 《吉林医学》 CAS 2010年第16期2549-2552,共4页 Jilin Medical Journal
  • 相关文献

参考文献1

二级参考文献21

  • 1向光大,曹红燕,曾尟枚,赵林双.1型糖尿病患者胰岛素治疗前后内皮依赖性血管舒张功能的变化[J].中国糖尿病杂志,2006,14(2):109-111. 被引量:5
  • 2Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89: 309-319.
  • 3Zhang J, Fu M, Myles D, et al. PDGF induces osteoprotegerin expression in vascular smooth muscle ceils by multiple signal pathways. FEBS letters, 2002, 521 : 180-184.
  • 4Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002, 106 : 1192-1194.
  • 5Schoppet M, Sattler AM, Schaefer JR, et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab, 2003, 88: 1024-1028.
  • 6Knudsen ST, Foss CH, Poulsen PL, et al. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol, 2003, 149 : 39- 42.
  • 7Avignon A, Sultan A, Plot C, et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care, 2005, 28: 2176-2180.
  • 8Galluzzi F, Stagi S, Salti R, et al. Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. Eur J Endocrinol, 2005, 153 : 879-885.
  • 9Xiang GD, Wu YH. Apolipoprotein e4 allele and endotheliumdependent arterial dilation in type 2 diabetes mellitus without angiopathy. Diabetologia, 2003, 46: 514-519.
  • 10Xiang GD, Wang YL. Regular aerobic exercise training improves endothelium-dependent artery dilation in patients with impaired fasting glucose. Diabetes Care, 2004, 27:801-802.

共引文献31

同被引文献52

  • 1吴巍,姚欣欣,朱辛奕.TGF-β在骨组织中作用的研究进展[J].吉林医药学院学报,2009,30(1):45-47. 被引量:12
  • 2Maaiatopoulos C,Sodek J,Melcher AH.Bone formation in vitro by stromal cells obtained from bone mallow of young adult rats.[Jl Cell Tissue Res, 1998,254(2):317-330.
  • 3Hu Z,Peel S A,Ho S K.et al,Role of bovine bone morpho- genetic proteins in frome matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation [J].J Craniofac Surg, 2005,16(6) : 1006-1014.
  • 4Sun LY,Hsieh DK,kn PC,Chiu HT,Chiou TW.Pulsed eleetro- magnetic fields accelerate proliferation and osteogenic gene expres- sion in human bone mMlow mesenchymal stem cells during os-teogenic differentlation[J].Bicelectromagnetics.2010,31(3) : 209-219.
  • 5Yang Yet al.EMF acts on rat bone ms/1-ow mesenehymal stem cells to promote differentiation to osteoblasts and to inhibit dif- ferentiation to adipoeytes [J].Bicelectromagnetics.2010,31 (4) : 277- 285.
  • 6Grayson WL,zhao F,Bunnel B,et al,Hypoxia enhmlces prolifera- tion and tissue formation of human mesenchymal stem cells.Hiochem Biophys Res commun,2007,358(3):948-953.
  • 7Robins Jc,Akeno N.Mukhcrjee A,et al,Hypoxia induces chondro- cyte-specific gene expression in mesenchymal cells in association with transcriptional activation of sox9,Bone,2005,37(3):313-322.
  • 8Hyun-Ju Cho,Hyun-Jai Cho,Hyo-Soo Kim.Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification[J]. Current Atherosclerosis Reports . 2009 (3)
  • 9Gordon JA,,Hunter GK,Goldberg HA.Activation of the mitogen-activated protein kinase pathway by bone sialoprotein regulatesosteoblast differentiation. Cells Tissues Organs . 2009
  • 10Miyazaki T,Kanatani N,Rokutanda S,et al.Inhibition of theterminal differentiation of odontoblasts and their transdifferenfiationinto osteoblasts in Runx2 transgenic mice. Archives of Histology and Cytology . 2008

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部